94 related articles for article (PubMed ID: 10231136)
21. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
[TBL] [Abstract][Full Text] [Related]
22. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
Br J Haematol; 2000 Dec; 111(3):774-81. PubMed ID: 11122137
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8.
Cull GM; Timms JM; Haynes AP; Russell NH; Irving WL; Ball JK; Thomson BJ
Br J Haematol; 1998 Mar; 100(4):793-6. PubMed ID: 9531351
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
Mateo G; Corral M; Almeida J; López-Berges C; Nieto mJ; García-Marcos A; Vázquez L; del Cañizo C; Orfao A; San Miguel JF
Haematologica; 2003 Sep; 88(9):1013-21. PubMed ID: 12969809
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
26. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
[TBL] [Abstract][Full Text] [Related]
27. Leukapheresis cells of patients with multiple myeloma collected after mobilization with chemotherapy and G-CSF do not bear Kaposi's sarcoma associated herpesvirus DNA.
Bellos F; Cremer FW; Ehrbrecht E; Goldschmidt H; Moos M
Br J Haematol; 1998 Dec; 103(4):1192-7. PubMed ID: 9886341
[TBL] [Abstract][Full Text] [Related]
28. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
29. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
30. Danish patients with untreated multiple myeloma do not harbour human herpesvirus 8.
Rask C; Kelsen J; Olesen G; Nielsen JL; Obel N; Abildgaard N
Br J Haematol; 2000 Jan; 108(1):96-8. PubMed ID: 10651731
[TBL] [Abstract][Full Text] [Related]
31. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
[TBL] [Abstract][Full Text] [Related]
32. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
[TBL] [Abstract][Full Text] [Related]
33. Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
Hosing C; Qazilbash MH; Kebriaei P; Giralt S; Davis MS; Popat U; Anderlini P; Shpall EJ; McMannis J; Körbling M; Champlin RE
Br J Haematol; 2006 Jun; 133(5):533-7. PubMed ID: 16681642
[TBL] [Abstract][Full Text] [Related]
34. High association of human herpesvirus 8 in large-plaque parapsoriasis and mycosis fungoides.
Kreuter A; Bischoff S; Skrygan M; Wieland U; Brockmeyer NH; Stücker M; Altmeyer P; Gambichler T
Arch Dermatol; 2008 Aug; 144(8):1011-6. PubMed ID: 18711073
[TBL] [Abstract][Full Text] [Related]
35. Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation.
Miyoshi H; Tanaka-Taya K; Hara J; Fujisaki H; Matsuda Y; Ohta H; Osugi Y; Okada S; Yamanishi K
Bone Marrow Transplant; 2001 May; 27(10):1065-70. PubMed ID: 11438822
[TBL] [Abstract][Full Text] [Related]
36. Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Gastineau DA; Tefferi A; Chen MG; Witzig TE; Greipp PR; Litzow MR
Bone Marrow Transplant; 2000 Jul; 26(1):45-50. PubMed ID: 10918404
[TBL] [Abstract][Full Text] [Related]
37. Cytological and cytochemical study of the peripheral blood mononuclear cells in leukapheresis products mobilized with rhG-CSF.
Villegas A; González FA; Armada B; Llorente L
Bone Marrow Transplant; 1996 Dec; 18(6):1199. PubMed ID: 8971397
[No Abstract] [Full Text] [Related]
38. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation.
Maeda Y; Teshima T; Yamada M; Shinagawa K; Nakao S; Ohno Y; Kojima K; Hara M; Nagafuji K; Hayashi S; Fukuda S; Sawada H; Matsue K; Takenaka K; Ishimaru F; Ikeda K; Niiya K; Harada M
Br J Haematol; 1999 Apr; 105(1):295-302. PubMed ID: 10233397
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial.
Gupta S; Zhou P; Hassoun H; Kewalramani T; Reich L; Costello S; Drake L; Klimek V; Dhodapkar M; Teruya-Feldstein J; Hedvat C; Kalakonda N; Fleisher M; Filippa D; Qin J; Nimer SD; Comenzo RL
Bone Marrow Transplant; 2005 Mar; 35(5):441-7. PubMed ID: 15640822
[TBL] [Abstract][Full Text] [Related]
40. PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients.
Dominici M; Luppi M; Campioni D; Lanza F; Barozzi P; Milani R; Moretti S; Nadali G; Spanedda R; Trovato R; Torelli G; Castoldi G
Int J Cancer; 2000 Apr; 86(1):76-82. PubMed ID: 10728598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
